Kambiz Shekdar

Contributor

I obtained my Ph.D. at The Rockefeller University where I invented the novel cell engineering method Chromovert Technology and established several research organizations based on it.

tags:   Assay Technology     Big Data     Biologics     Biopharma news     CRISPR     Drug Targets     Network Biology     Open Science     Pharmaceutical industry trends     Thought-provoking     Biomedical Research     Biotech Research     Cell Therapies     Drug Discovery and Development     Epigenetics Research     Gene editing     Genetic Engineering     Medicinal Chemistry     Nanomedicine     Omics Research     Pharmacogenomics and Personalized Medicine     Pharmacology and Toxicology     Research Equipment and Tools     Stem-Cell Research/Therapy     Translational Research     CNS     Neurosciences     Pain     Vaccine Development    

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

Secondcell Bio Publishes Biotechnology for Improved Drug Discovery Originating from The Rockefeller University

   145
Secondcell Bio Publishes Biotechnology for Improved Drug Discovery Originating from The Rockefeller University
  • Chromovert® Technology permits the creation of previously out-of-reach cells that mimic the biology of human disease in the laboratory dish.
  • The technology provides Drugomics™ as a therapeutics discovery follow-up to Genomics-era efforts that identified human disease genes.
  • Secondcell Bio has partnered with Gene Link, Inc. to market research materials to operate Chromovert to interested cell and genetic engineers everywhere.
  • Discovery and development of a novel non-addictive pain blocker fast tracked by the FDA to treat the opioid epidemic broadly validates Chromovert Technology.